Literature DB >> 12587853

Annotation: The use of psychotropic medications in children: an American view.

Mark L Wolraich1.   

Abstract

BACKGROUND: Psychotropic medications have become an integral component in the treatment of children with mental illnesses.
METHODS: Selective reviews of the empirical evidence for the efficacy of psychotropic medications and studies of their use patterns were reviewed.
RESULTS: Very strong efficacy for at least the short-term benefits and safety of stimulant medications was found and some good efficacy and safety evidence for the treatment of anxiety and depressive disorders with seratonin reuptake inhibitors (SSRI) was also found. Efficacy for tricyclic antidepressants to treat attention deficit hyperactivity disorder was found but the presence of significant side effects makes them less the drugs of choice. Other medications are presented but with less rigorous evidence. Studies of use found that stimulant medications are extensively prescribed in the US by both psychiatrists and primary care physicians. SSRI are also prescribed extensively but not to the extent of stimulants and are more frequently prescribed by psychiatrists.
CONCLUSIONS: There is now good evidence for the efficacy of some psychotropic agents and their use is an integral component in the management of childhood mental illnesses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587853     DOI: 10.1111/1469-7610.00110

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  8 in total

1.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

2.  Adverse effects of psychotropic medications in children: predictive factors.

Authors:  Ajit Ninan; Shannon L Stewart; Laura A Theall; Shehan Katuwapitiya; Chester Kam
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-09

3.  The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Authors:  Bradley D Stein; Emily Leckman-Westin; Edward Okeke; Deborah M Scharf; Mark Sorbero; Qingxian Chen; Ka Ho Brian Chor; Molly Finnerty; Jennifer P Wisdom
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-08-21       Impact factor: 2.576

Review 4.  Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.

Authors:  Mark L Wolraich; Laura McGuinn; Melissa Doffing
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.

Authors:  Bianca D Patel; Drew H Barzman
Journal:  Psychiatr Q       Date:  2013-12

6.  The role of pharmacotherapy in the management of self-regulation difficulties in young children.

Authors:  Pratibha N Reebye; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05

7.  Pharmacotherapy of aggression in children and adolescents: efficacy and effect size.

Authors:  Elizabeth Pappadopulos; Sophie Woolston; Alanna Chait; Matthew Perkins; Daniel F Connor; Peter S Jensen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-02

8.  Cost-utility analysis of different treatments for post-traumatic stress disorder in sexually abused children.

Authors:  Elena Gospodarevskaya; Leonie Segal
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2012-04-10       Impact factor: 3.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.